Clinical trial

Quetiapine and the Dopaminergic Epigenetic Control

NCT00370500

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-04-01

PhasePHASE4

Study timeline

Study start (unknown)2007-04-01Date precision: month

Registry last updated2020-12-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Quetiapine fumarateDRUG · verified · RxNorm: quetiapine fumarate

Sponsors & collaborators

University of Erlangen-Nürnberg Medical Schoollead sponsor

AstraZenecacollaborator

Mapped research locations

ErlangenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00370500 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.